Stručni rad

https://doi.org/10.20471/LO.2025.53.01.01

Breast cancer radiotherapy in pregnancy

Katarina Antunac orcid.org/0000-0002-8356-9897 ; University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Ivona Odobašić ; University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Iva Andrašek ; University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Martina Mikulandra orcid.org/0000-0001-9287-7149 ; University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb and Clinical Oncology Department, School of Medicine, University of Zagreb, Zagreb, Croatia
Lidija Beketić-Orešković ; University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb and Clinical Oncology Department, School of Medicine, University of Zagreb, Zagreb, Croatia

Sažetak

Adjuvant radiotherapy for breast cancer reduces the risk of locoregional recurrence, distant disease and improves the survival of breast cancer patients. The incidence of breast cancer in pregnancy is constantly increasing, and it is expected that an increasing number of pregnant breast cancer patients will require radiation. Ionizing radiation can have a harmful effect on the fetus, which depends on the radiation dose and the gestational age of the fetus at the time of exposure to ionizing radiation. Pregnancy is not an absolute contraindication to radiotherapy for breast cancer, provided that radiation is carefully planned and appropriate protection is used.

Ključne riječi

breast cancer; radiotherapy; breast cancer in pregnancy

Hrčak ID:

334404

URI

https://hrcak.srce.hr/334404

Datum izdavanja:

21.8.2025.

Podaci na drugim jezicima: hrvatski

Posjeta: 871 *